<--- Back to Details
First PageDocument Content
Endocrine system / Neuroendocrine tumor / Multiple endocrine neoplasia type 1 / Carcinoid syndrome / 5-Hydroxyindoleacetic acid / Carcinoid / Zollinger–Ellison syndrome / Chromogranin A / Somatostatin / Medicine / Oncology / Health
Date: 2012-06-18 21:28:45
Endocrine system
Neuroendocrine tumor
Multiple endocrine neoplasia type 1
Carcinoid syndrome
5-Hydroxyindoleacetic acid
Carcinoid
Zollinger–Ellison syndrome
Chromogranin A
Somatostatin
Medicine
Oncology
Health

…………………… was normal at 20 ng/L

Add to Reading List

Source URL: www.carcinoid.org

Download Document from Source Website

File Size: 28,16 KB

Share Document on Facebook

Similar Documents

Medical physics / Physics / Radiation therapy / Radiobiology / Medicine / Radiation / Fast neutron therapy / Neutron / Calibration / Dosimetry / Collimator

Clinical Neutron Therapy System Reference Manual Jonathan Jacky1 Ruedi Risler Radiation Oncology, Box

DocID: 1xVse - View Document

Humancomputer interaction / User interface techniques / Human behavior / Software architecture / Computing / Computer / User interface / Graphical user interface

Formal Development of a Graphical User Interface for a Radiation Therapy Machine Jonathan Jacky  Jonathan Unger Radiation Oncology Department RC-08 University of Washington

DocID: 1xViy - View Document

Health / Computing / Medical physics / Formal methods / Theoretical computer science / Therapy / Information and communications technology / Radiation therapy / Z notation / Computer / Software

Experience with Z Developing a Control Program for a Radiation Therapy Machine Jonathan Jacky , Jonathan Unger, Michael Patrick and Ruedi Risler Radiation Oncology Box

DocID: 1xV2d - View Document

Computing / Models of computation / Software engineering / Control engineering / Cognition / State / Control theory / Lookup table / Variable / Dependent and independent variables

Formal Speci cation and Development of Control System Input/Output Jonathan Jacky Radiation Oncology Department RC-08 University of Washington

DocID: 1xUvZ - View Document

Medicine / Clinical medicine / Cancer / Tyrosine kinase receptors / Breast cancer / Atezolizumab / ROS1 / Triple-negative breast cancer / Anaplastic lymphoma kinase / Trastuzumab emtansine / Entrectinib / Metastatic breast cancer

European Society for Medical Oncology (ESMOCongress Roche Analyst Audio Webcast Monday, 22 October 2018 Welcome Daniel O’Day, CEO Roche Pharmaceuticals

DocID: 1xTgE - View Document